Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06361238
PHASE3

Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

View on ClinicalTrials.gov

Summary

This study aims to clarify the preventive effect of perioperative liraglutide application on postoperative delirium in elderly patients with Type 2 diabetes undergoing cardiac surgery.

Official title: Perioperative Application of Liraglutide for the Prevention of Postoperative Delirium Among Elderly Patients with Type 2 Diabetes Undergoing Cardiac Surgery: a Single-Center Randomized Controlled Study

Key Details

Gender

All

Age Range

60 Years - Any

Study Type

INTERVENTIONAL

Enrollment

260

Start Date

2024-11-19

Completion Date

2028-03-31

Last Updated

2024-12-20

Healthy Volunteers

No

Interventions

DRUG

Liraglutide injection

Subcutaneous injection of liraglutide: 0.6 mg administered the day before surgery, 1.8 mg administered post-anesthesia induction on the day of surgery, followed by 0.6 mg daily for the first three postoperative days.

DRUG

Placebo injection

Subcutaneous injection of Placebo: the same volume as liraglutide administrated at the corresponding times.

Locations (1)

Wenxue liu

Nanjing, Jiangsu, China